Monday, August 24, 2026

Emerging Threat: H9N2 Bird Flu Case Detected in Young Child

On June 11, the World Health Organization...

Discover Vuori: The First Premium Activewear Brand Now Available Online at Shinsegae Duty-Free!

Shinsegae Duty Free introduces Vuori activewear, blending fitness and fashion, boosting online sales by 30% in Q1.

How the New South-North Forest Cooperation Pact Aims for 2050 Carbon Neutrality

The Korea Arboreta and Gardens Institute signed an agreement to preserve forest ecosystems and combat climate change on the Korean Peninsula.

Tag: AriBio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Unlocking the Future of Neuroscience: AriBio’s Partnership with Lilly TuneLab for Advanced AI Drug Development

AriBio partners with Eli Lilly's AI platform, Lilly TuneLab, to enhance drug development for neurodegenerative diseases using advanced AI.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.